Trials / Completed
CompletedNCT02186990
Comparison of Etomidate, Propofol and Etomidate-propofol Combination in Terms of Effects on Haemodynamic Response to Intubation
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 90 (actual)
- Sponsor
- Ordu University · Academic / Other
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate the effect of propofol, etomidate and propofol-etomidate combination on hemodynamic responses during laryngoscopy and tracheal intubation and assess the adverse effect related to this drugs.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | propofol | 2,5 mg/kg |
| DRUG | etomidate | 0,3 mg/kg |
| DRUG | etomidate-propofol | 0,15 mg/kg etomidate + 1,25 mg/kg propofol |
Timeline
- Start date
- 2014-05-01
- Primary completion
- 2014-08-01
- First posted
- 2014-07-10
- Last updated
- 2014-08-13
Locations
1 site across 1 country: Turkey (Türkiye)
Source: ClinicalTrials.gov record NCT02186990. Inclusion in this directory is not an endorsement.